title: Intensive insulin for type 2 diabetes: the risk of causing harm.
authors.affiliation: ACT Health Diabetes Service and Australian National University Medical School, Canberra, ACT, Australia 2606. Electronic address: christopher.nolan@anu.edu.au.
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Nolan
authors.affiliation: Diabetes Research Unit, Boston University Medical Center, Boston, MA, USA.
authors.forename: Neil B
authors.initials: NB
authors.lastname: Ruderman
authors.affiliation: CR-CHUM and Montreal Diabetes Research Center and Departments of Nutrition and Biochemistry, University of Montreal, Montreal, QC, Canada.
authors.forename: Marc
authors.initials: M
authors.lastname: Prentki
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic / Q000379:methods; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D007328:Insulin / Q000008:administration & dosage* / Q000009:adverse effects; D007333:Insulin Resistance / Q000502:physiology; D012307:Risk Factors
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin